Description
Daveris (Travoprost) Eye Drops 40 mcg/ml – 2.5 ml Vial
Ingredients
Active Ingredient: Travoprost 40 mcg/ml.
Mechanism of Action
Pharmacological Properties: Travoprost, the active ingredient in Daveris eye drops, increases the outflow of aqueous humor from the eye, leading to a reduction in intraocular pressure. This mechanism of action is crucial for managing conditions such as glaucoma.
Indications for Use
Indications: Daveris eye drops are indicated for the reduction of elevated intraocular pressure in patients diagnosed with open-angle glaucoma or ocular hypertension.
Contraindications
Contraindications: Avoid using Daveris eye drops if you have a known allergy to travoprost or any other components of the formulation.
Side Effects
Side Effects: Common side effects may include ocular irritation, stinging, or changes in iris color. Contact your healthcare provider if you experience any persistent or severe side effects.
Usage Instructions
Directions: Before instilling the drops, ensure your hands are clean. Tilt your head back, pull down the lower eyelid, and administer one drop into the affected eye(s) once daily in the evening. Close your eye for 1 to 2 minutes after application.
Benefits Compared to Analogues
Daveris eye drops containing travoprost offer a potent reduction in intraocular pressure, making them an effective choice for managing glaucoma and ocular hypertension when compared to other medications in the same class.
Suitable Patient Groups
Daveris eye drops are suitable for adult patients diagnosed with open-angle glaucoma or ocular hypertension. The dosage may need adjustment in elderly patients or those with specific health conditions; consult your healthcare provider for personalized recommendations.
Storage and Shelf Life
Store Daveris eye drops in a cool, dry place away from direct sunlight. Ensure the vial is tightly closed when not in use. Check the expiration date on the packaging and do not use the product beyond this date.
Packaging Description
The Daveris eye drops come in a 2.5 ml vial containing a solution of travoprost 40 mcg/ml. The packaging is designed to maintain the sterility and integrity of the product until opened.
Clinical Evidence and Proven Effectiveness
Clinical Studies: Studies have shown that Daveris eye drops with travoprost effectively reduce intraocular pressure in patients with glaucoma. Research by Alm et al. (2005) demonstrated the sustained efficacy and tolerability of travoprost over a 12-month treatment period.
